Peel Hunt restated their hold rating on shares of Assura (LON:AGR) in a research report report published on Tuesday, ThisIsMoney.Co.Uk reports.
Separately, Liberum Capital restated a hold rating on shares of Assura in a research report on Tuesday, July 2nd.
Shares of Assura stock opened at GBX 70.60 ($0.92) on Tuesday. The company has a debt-to-equity ratio of 53.61, a quick ratio of 0.39 and a current ratio of 0.73. The stock has a market cap of $1.70 billion and a P/E ratio of 20.17. The stock’s fifty day moving average is GBX 67.92 and its 200 day moving average is GBX 62.67. Assura has a one year low of GBX 52.40 ($0.68) and a one year high of GBX 71.80 ($0.94).
The firm also recently announced a dividend, which will be paid on Wednesday, October 16th. Shareholders of record on Thursday, September 12th will be given a dividend of GBX 0.69 ($0.01) per share. This represents a yield of 0.97%. The ex-dividend date is Thursday, September 12th. Assura’s payout ratio is currently 0.86%.
In other Assura news, insider Jonathan Murphy sold 102,907 shares of Assura stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of GBX 65 ($0.85), for a total transaction of £66,889.55 ($87,403.04). Also, insider Orla Ball sold 9,733 shares of Assura stock in a transaction dated Monday, September 9th. The stock was sold at an average price of GBX 71 ($0.93), for a total transaction of £6,910.43 ($9,029.70).
Assura Company Profile
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high-quality patient care in the community.
Featured Story: Stock Portfolio Tracker
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.